Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type B (MAO-B). Rasagiline demonstrates complete and selective ...
Hosted on MSN2mon
Monoamine neurotransmitters emerge as architects of brain physiologyBy uncovering how these histone modifications influence the brain, the team has identified a novel mechanism for controlling circadian gene expression and behavioral rhythms. The team's findings ...
Clinical and Pharmacological Effects of Monoamine Precursors or Haloperidol in Chronic Schizophrenia
Persson, T., and Roos, B.-E., Lancet, ii, 987 (1967). Coppen, A., Shaw, D. M., Herzberg, B., and Maggs, R., Lancet, ii, 1178 (1967). Sjoerdsma, A., Oates, J. A ...
Announcing a new publication for Acta Materia Medica journal. Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depressive disorders. Understanding the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback